Candriam Equities L Oncology Impact C/ LU1864481541 /
| NAV2024-04-18 | Chg.-0.7000 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 222.6300USD | -0.31% | paying dividend | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | 6.11 | 2.59 | -3.71 | -2.64 | 8.63 | 0.22 | -0.35 | -3.24 | 5.02 | 7.89 | 4.95 | +30.34% |
| 2020 | -1.52 | -5.41 | -3.15 | 12.05 | 8.47 | 1.34 | 4.36 | 2.08 | 3.44 | -2.27 | 5.74 | 3.79 | +31.33% |
| 2021 | 0.48 | -4.26 | -0.16 | 2.26 | 0.10 | 3.44 | -1.04 | 5.49 | -3.84 | 3.30 | -6.44 | 3.90 | +2.49% |
| 2022 | -10.55 | -1.82 | 4.57 | -5.92 | -1.41 | -0.04 | 4.29 | -3.22 | -4.78 | 6.96 | 5.99 | -3.52 | -10.50% |
| 2023 | 2.07 | -3.95 | 1.30 | 2.76 | -2.64 | 0.00 | 0.81 | -2.09 | -5.31 | -6.44 | 9.13 | 5.65 | +0.17% |
| 2024 | 1.29 | 4.06 | 1.42 | -6.41 | - | - | - | - | - | - | - | - | - |
Single months: Dividends not considered
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 10.93% | 12.73% | 11.88% | 14.74% | 17.30% |
| Sharpe ratio | -0.35 | 1.57 | -0.54 | -0.40 | 0.27 |
| Best month | +5.65% | +9.13% | +9.13% | +9.13% | +12.05% |
| Worst month | -6.41% | -6.44% | -6.44% | -10.55% | -10.55% |
| Maximum loss | -6.87% | -6.87% | -17.00% | -26.56% | -26.56% |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,215.3799 | -1.24% | -2.07% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,367.0300 | -1.11% | -1.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 192.3800 | -4.57% | -12.11% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,116.2300 | -1.69% | +9.02% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,495.0601 | -1.55% | -3.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 231.2700 | +0.33% | +6.37% | |
| Candriam Equities L Oncology Imp... | paying dividend | 222.6300 | -2.48% | -5.69% | |
| Candriam Equities L Oncology Imp... | paying dividend | 180.1100 | -1.64% | -3.29% | |
| Candriam Equities L Oncology Imp... | paying dividend | 19,777.0000 | -4.48% | -4.95% | |
| Candriam Equities L Oncology Imp... | reinvestment | 149.7300 | -1.80% | +8.66% | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,954.4700 | -3.66% | -9.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 244.8700 | +1.19% | +9.08% | |
| Candriam Equities L Oncology Imp... | reinvestment | 191.9700 | -4.95% | -13.14% | |
| Candriam Equities L Oncology Imp... | reinvestment | 264.8100 | -1.65% | -3.30% | |
| Candriam Equities L Oncology Imp... | reinvestment | 179.5200 | -3.77% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,745.0500 | -1.37% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,661.9299 | -1.55% | -3.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 148.7500 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 253.5600 | -2.48% | -5.71% |
Performance
| YTD | +0.04% | ||
|---|---|---|---|
| 6 Months | +11.29% | ||
| 1 Year | -2.48% | ||
| 3 Years | -5.69% | ||
| 5 Years | +50.46% | ||
| Since start | +57.34% | ||
| Year | |||
| 2023 | +0.17% | ||
| 2022 | -10.50% | ||
| 2021 | +2.49% | ||
| 2020 | +31.33% | ||
| 2019 | +30.34% | ||
Dividends
| 2023-04-28 | 3.39 USD |
| 2022-04-28 | 4.28 USD |
| 2021-04-28 | 4.15 USD |
| 2020-04-24 | 1.50 USD |
